These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12719580)

  • 121. A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.
    Gach JS; Quendler H; Tong T; Narayan KM; Du SX; Whalen RG; Binley JM; Forthal DN; Poignard P; Zwick MB
    PLoS One; 2013; 8(8):e72054. PubMed ID: 23991039
    [TBL] [Abstract][Full Text] [Related]  

  • 122. B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates.
    Ota T; Doyle-Cooper C; Cooper AB; Doores KJ; Aoki-Ota M; Le K; Schief WR; Wyatt RT; Burton DR; Nemazee D
    J Immunol; 2013 Sep; 191(6):3179-85. PubMed ID: 23940273
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.
    Quinnan GV; Zhang P; Dong M; Chen H; Feng YR; Lewis M; Broder CC
    PLoS One; 2013; 8(3):e59803. PubMed ID: 23533650
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Anti-idiotypic monobodies derived from a fibronectin scaffold.
    Sullivan MA; Brooks LR; Weidenborner P; Domm W; Mattiacio J; Xu Q; Tiberio M; Wentworth T; Kobie J; Bryk P; Zheng B; Murphy M; Sanz I; Dewhurst S
    Biochemistry; 2013 Mar; 52(10):1802-13. PubMed ID: 23394681
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
    Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
    PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.
    Benjelloun F; Lawrence P; Verrier B; Genin C; Paul S
    J Virol; 2012 Dec; 86(24):13152-63. PubMed ID: 23015715
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Anti-idiotypic monobodies for immune response profiling.
    Sullivan MA; Wentworth T; Kobie JJ; Sanz I
    Methods; 2012 Sep; 58(1):62-8. PubMed ID: 22819856
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Basic research in HIV vaccinology is hampered by reductionist thinking.
    Van Regenmortel MH
    Front Immunol; 2012; 3():194. PubMed ID: 22787464
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
    Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides.
    Kramski M; Center RJ; Wheatley AK; Jacobson JC; Alexander MR; Rawlin G; Purcell DF
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4310-9. PubMed ID: 22664963
    [TBL] [Abstract][Full Text] [Related]  

  • 131. A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.
    Mediouni S; Watkins JD; Pierres M; Bole A; Loret EP; Baillat G
    J Biol Chem; 2012 Apr; 287(15):11942-50. PubMed ID: 22362765
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Complex binding sites made to order.
    Scott JK; Pantophlet R; Craig L
    Nat Biotechnol; 2012 Feb; 30(2):154-5. PubMed ID: 22318033
    [No Abstract]   [Full Text] [Related]  

  • 133. An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.
    Ahmed FK; Clark BE; Burton DR; Pantophlet R
    Vaccine; 2012 Jan; 30(5):922-30. PubMed ID: 22142583
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
    Van Regenmortel MH
    Arch Virol; 2012 Jan; 157(1):1-20. PubMed ID: 22012269
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.
    Liu L; Wen M; Wang W; Wang S; Yang L; Liu Y; Qian M; Zhang L; Shao Y; Kimata JT; Zhou P
    J Virol; 2011 Sep; 85(17):8467-76. PubMed ID: 21715497
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
    Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
    [TBL] [Abstract][Full Text] [Related]  

  • 137. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?
    Klasse PJ; Sanders RW; Cerutti A; Moore JP
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):1-15. PubMed ID: 21495876
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease.
    Breden F; Lepik C; Longo NS; Montero M; Lipsky PE; Scott JK
    PLoS One; 2011 Mar; 6(3):e16857. PubMed ID: 21479208
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.
    Gift SK; McFadden K; Zentner IJ; Rajagopal S; Zhang MY; Dimitrov DS; Chaiken IM
    Biochemistry; 2011 Apr; 50(14):2769-79. PubMed ID: 21417283
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
    Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
    J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.